Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 23,039,160
- Share change
- +2,069,187
- Total reported value
- $2,704,675,917
- Put/Call ratio
- 86%
- Price per share
- $117.40
- Number of holders
- 182
- Value change
- +$256,730,169
- Number of buys
- 99
- Number of sells
- 76
Report period
Q2 2023
Institutions
182
Top holders
10
KRYS full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7.5%
|
2,196,958
|
$175,888,457 | — | 31 Mar 2023 | |
| Redmile Group, LLC |
13F
|
Company |
6.5%
|
1,913,280
|
$153,177,197 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.9%
|
1,750,000
|
$140,105,000 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.8%
|
1,716,095
|
$137,390,566 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
1,202,230
|
$96,250,534 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
1,026,395
|
$82,173,184 | — | 31 Mar 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
3.3%
|
961,242
|
$76,957,000 | — | 31 Mar 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.2%
|
945,407
|
$75,689,284 | — | 31 Mar 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.1%
|
632,824
|
$50,663,889 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.1%
|
632,393
|
$50,629,384 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.7%
|
502,400
|
$40,222,144 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
462,090
|
$36,994,210 | — | 31 Mar 2023 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.5%
|
447,393
|
$35,818,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
430,571
|
$34,471,514 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
1.4%
|
412,082
|
$32,991,000 | — | 31 Mar 2023 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
1.3%
|
374,718
|
$29,999,923 | — | 31 Mar 2023 | |
| BRAIDWELL LP |
13F
|
Company |
1.2%
|
348,036
|
$27,863,762 | — | 31 Mar 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.1%
|
311,949
|
$24,974,637 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1%
|
302,716
|
$24,235,443 | — | 31 Mar 2023 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.97%
|
286,018
|
$22,899,000 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.88%
|
257,860
|
$20,644,271 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.81%
|
238,409
|
$19,087,000 | — | 31 Mar 2023 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.77%
|
225,809
|
$18,078,000 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.72%
|
212,130
|
$16,983,127 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
201,477
|
$16,130,248 | — | 31 Mar 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.67%
|
195,980
|
$15,690,159 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
159,889
|
$12,800,713 | — | 31 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.46%
|
136,141
|
$10,899,000 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
126,825
|
$10,153,609 | — | 31 Mar 2023 | |
| S SQUARED TECHNOLOGY, LLC |
13F
|
Company |
0.37%
|
108,215
|
$8,663,693 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.36%
|
107,325
|
$8,592,440 | — | 31 Mar 2023 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.36%
|
105,200
|
$8,422,000 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.32%
|
93,644
|
$7,497,139 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
92,887
|
$7,436,533 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.31%
|
92,000
|
$6,779,438 | — | 31 Mar 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.29%
|
85,179
|
$6,819,431 | — | 31 Mar 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.29%
|
85,000
|
$6,805,100 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
79,563
|
$6,369,814 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.21%
|
61,524
|
$4,925,611 | — | 31 Mar 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.21%
|
61,000
|
$4,883,660 | — | 31 Mar 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
53,932
|
$4,317,796 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
52,931
|
$4,238,000 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
51,580
|
$4,129,495 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.17%
|
50,585
|
$4,049,835 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.16%
|
48,101
|
$3,850,966 | — | 31 Mar 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.15%
|
45,235
|
$3,622,000 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.14%
|
41,135
|
$3,293,268 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
38,900
|
$3,114,334 | — | 31 Mar 2023 | |
| CWM, LLC |
13F
|
Company |
0.12%
|
35,165
|
$2,815,000 | — | 31 Mar 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
34,014
|
$2,723,161 | — | 31 Mar 2023 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q2 2023
As of 30 Jun 2023,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
182 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,039,160 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., Frazier Life Sciences Management, L.P., STATE STREET CORP, LORD, ABBETT & CO. LLC, Point72 Asset Management, L.P., and DIMENSIONAL FUND ADVISORS LP.
This page lists
182
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
159
Q2 2023 holders
182
Holder diff
23
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.